BONE MINERAL DENSITY RESPONSE TO ENZYME REPLACEMENT THERAPY OVER 2 YEARS IN ADULTS WITH TYPE 1 GAUCHER DISEASE

被引:0
|
作者
Zimran, A. [1 ,2 ]
Gonzalez, D. E. [3 ]
Kabra, M. [4 ]
Lukina, E. A. [5 ]
Giraldo, P. [6 ,7 ]
Kisinovsky, I [8 ]
Bavdekar, A. [9 ]
Ben Dridi, M-F [10 ]
Gupta, N. [4 ]
Kishnani, P. S. [11 ]
Mehta, A. [12 ]
Elstein, D. [1 ,2 ]
Wang, N. [13 ]
Hangartner, T. N. [14 ]
Crombez, E. [13 ]
Ben Turkia, H. [10 ]
机构
[1] Shaare Zedek Med Cent, Jerusalem, Israel
[2] Hebrew Univ Jerusalem, Hadassah Med Sch, IL-91010 Jerusalem, Israel
[3] Sanatorio Espanol, Asuncion, Paraguay
[4] All India Inst Med Sci, New Delhi, India
[5] Minist Publ Hlth Russia, Hematol Res Ctr, Moscow, Russia
[6] CIBERER, Zaragoza, Spain
[7] Hosp Univ Miguel Servet, Zaragoza, Spain
[8] Your Hlth SA, Buenos Aires, DF, Argentina
[9] KEM Hosp Res Ctr, Pune, Maharashtra, India
[10] La Rabta Hosp, Tunis, Tunisia
[11] Duke Univ, Med Ctr, Durham, NC USA
[12] UCL, London, England
[13] Shire HGT, Lexington, MA USA
[14] Wright State Univ, Dayton, OH 45435 USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:S149 / S149
页数:1
相关论文
共 50 条
  • [1] The effect of enzyme replacement therapy with imiglucerase on bone mineral density in type 1 Gaucher disease
    Wenstrup, R.
    Kaplan, P.
    Pastores, G.
    Prakash-Cheng, A.
    Zimran, A.
    Hangartner, T.
    CLINICAL THERAPEUTICS, 2007, 29 : S117 - S117
  • [2] Effect of enzyme replacement therapy on bone mineral density in type 1 Gaucher disease.
    Wenstrup, R
    Kacena, K
    Kaplan, P
    Pastores, G
    Prakash-Cheng, A
    Zimran, A
    Hangartner, T
    BLOOD, 2005, 106 (11) : 54B - 54B
  • [3] The effect of enzyme replacement therapy with imiglucerase on bone mineral density in type I Gaucher disease
    Zimran, Ari
    Kacena, K. A.
    Kaplan, P.
    Pastores, G.
    Prakash-Cheng, A.
    Hangartner, T.
    Wenstrup, R.
    MOLECULAR GENETICS AND METABOLISM, 2007, 92 (04) : S33 - S33
  • [4] Response of Gaucher bone disease to enzyme replacement therapy
    Poll, LW
    Maas, M
    Terk, MR
    Roca-Espiau, M
    Bembi, B
    Ciana, G
    Weinreb, NJ
    BRITISH JOURNAL OF RADIOLOGY, 2002, 75 : A25 - A36
  • [5] Bone mineral density change in type 1 Gaucher disease adults given velaglucerase alfa for 2 years
    Zimran, An
    Giraldo, Pilar
    Zahrieh, David
    Crombez, Eric
    Cohn, Gabriel
    Elstein, Deborah
    MOLECULAR GENETICS AND METABOLISM, 2013, 108 (02) : S101 - S101
  • [6] Alendronate disodium improves bone mineral density in adults receiving enzyme replacement therapy (ERT) for Gaucher disease.
    Wenstrup, RJ
    Bailey, L
    Grabowski, GA
    Guo, S
    AMERICAN JOURNAL OF HUMAN GENETICS, 2001, 69 (04) : 674 - 674
  • [7] The effect of enzyme replacement therapy on bone crisis and bone pain in patients with type 1 Gaucher disease - Response
    Charrow, J.
    Dulisse, B.
    Grabowski, G. A.
    Weinreb, N. J.
    CLINICAL GENETICS, 2007, 72 (02) : 161 - 161
  • [8] Gaucher disease: alendronate disodium improves bone mineral density in adults receiving enzyme therapy
    Wenstrup, RJ
    Bailey, L
    Grabowski, GA
    Moskovitz, J
    Oestreich, AE
    Wu, W
    Sun, SM
    BLOOD, 2004, 104 (05) : 1253 - 1257
  • [9] Enzyme replacement therapy in type 2 Gaucher disease
    Tournay, A
    Parker, C
    Schiffman, R
    Brady, R
    Barton, N
    NEUROLOGY, 1996, 46 (02) : 1106 - 1106
  • [10] Effect of enzyme replacement therapy on bone density in Gaucher disease.
    Azuri, J
    Elstein, D
    Itzchaki, M
    Lahad, A
    Zimran, A
    Foldes, AJ
    JOURNAL OF BONE AND MINERAL RESEARCH, 2000, 15 : S487 - S487